[CARDINAL                                    NEWS RELEASE
     LOGO]
5555 GLENDON COURT
DUBLIN, OHIO  43016
(614) 717-5000

                                  FOR IMMEDIATE RELEASE
                                  TUESDAY, JULY 28, 1998

                                  FOR ADDITIONAL INFORMATION, CONTACT:

                                  Debra Dendahl Hadley
                                  Director, Investor Relations
                                  (614) 717-7481



                          CARDINAL HEALTH SHAREHOLDERS
                           APPROVE R.P. SCHERER MERGER


      DUBLIN, OHIO, JULY 28, 1998 - At a special meeting held earlier today,
shareholders of Cardinal Health, Inc. (NYSE: CAH) overwhelmingly approved the
company's pending merger with R.P. Scherer Corporation (NYSE: SHR). Scherer
stockholders are scheduled to vote on the merger at a special meeting to be held
on August 6, 1998.

      "Our relationship with R.P. Scherer has continued to develop very
positively since the announcement of our merger agreement," commented Robert D.
Walter. "We are extremely encouraged by the opportunities we see for our two
companies to work together."

      Under the terms of the agreement, shareholders of Scherer will receive a
fixed exchange of .95 shares of Cardinal Health common stock for each share of
Scherer common stock upon satisfaction of certain conditions, including approval
by Scherer stockholders.

      R.P. Scherer Corporation, an international developer and manufacturer of
drug delivery systems, is the world's largest producer of soft gelatin capsules
("softgels"). The company is currently developing and commercializing a variety
of advanced drug delivery systems. The company's proprietary drug delivery
systems improve the efficacy of drugs by regulating the dosage so as to ease
administration, increase absorption, enhance bioavailability and control the
time and place of release. The company operates a global network of 19
facilities in 12 countries.


                                    --more--

Cardinal Health/Shareholder Approval
Page 2


      Cardinal Health, Inc., a Fortune 200 company based in Dublin, Ohio, is one
of the country's leading healthcare service companies. Cardinal provides
innovative, cost-effective pharmaceutical services that improve the medication
use process to a broad base of customers nationwide. These services include
pharmaceutical distribution, hospital pharmacy management, automated dispensing
system manufacturing, pharmaceutical packaging, retail pharmacy franchising, and
clinical information systems development. The common stock of Cardinal Health,
Inc. is a component of the Standard & Poor's 500 Index.

      Some of the information included in this press release includes
"forward-looking statements" which are subject to uncertainties which could
cause actual results to differ materially from those projected or implied. The
most significant of such uncertainties are described in Cardinal's Form 10-K,
10-Q, and 8-K Reports and exhibits to those Reports filed with the Securities
and Exchange Commission.

                                ###